DE3586993D1 - Kontinuierliche intravenoese infusion von adenosin an menschlichen patienten, einheitsdosierungsform von adenosin und dessen verwendung bei der herstellung von arzneimitteln. - Google Patents

Kontinuierliche intravenoese infusion von adenosin an menschlichen patienten, einheitsdosierungsform von adenosin und dessen verwendung bei der herstellung von arzneimitteln.

Info

Publication number
DE3586993D1
DE3586993D1 DE8585905544T DE3586993T DE3586993D1 DE 3586993 D1 DE3586993 D1 DE 3586993D1 DE 8585905544 T DE8585905544 T DE 8585905544T DE 3586993 T DE3586993 T DE 3586993T DE 3586993 D1 DE3586993 D1 DE 3586993D1
Authority
DE
Germany
Prior art keywords
adenosine
infusion
production
dosage form
unit dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8585905544T
Other languages
English (en)
Other versions
DE3586993T2 (de
DE3586993T3 (de
Inventor
Alf Sollevi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Item Development AB
Original Assignee
Item Development AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25116698&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3586993(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Item Development AB filed Critical Item Development AB
Application granted granted Critical
Publication of DE3586993D1 publication Critical patent/DE3586993D1/de
Publication of DE3586993T2 publication Critical patent/DE3586993T2/de
Publication of DE3586993T3 publication Critical patent/DE3586993T3/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE3586993T 1985-09-24 1985-10-29 Kontinuierliche intravenöse infusion von adenosin an menschlichen patienten, einheitsdosierungsform von adenosin und dessen verwendung bei der herstellung von arzneimitteln. Expired - Fee Related DE3586993T3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77951685A 1985-09-24 1985-09-24
PCT/SE1985/000423 WO1987001593A1 (en) 1985-09-24 1985-10-29 Continuous intravenous infusion of adenosine to human patients, a unit dosage form of adenosine and use of adenosine for the manufacture of medicaments

Publications (3)

Publication Number Publication Date
DE3586993D1 true DE3586993D1 (de) 1993-02-25
DE3586993T2 DE3586993T2 (de) 1993-04-29
DE3586993T3 DE3586993T3 (de) 1998-03-19

Family

ID=25116698

Family Applications (4)

Application Number Title Priority Date Filing Date
DE19853590855 Withdrawn DE3590855T1 (de) 1985-09-24 1985-10-29
DE3586993T Expired - Fee Related DE3586993T3 (de) 1985-09-24 1985-10-29 Kontinuierliche intravenöse infusion von adenosin an menschlichen patienten, einheitsdosierungsform von adenosin und dessen verwendung bei der herstellung von arzneimitteln.
DE1999175044 Active DE19975044I2 (de) 1985-09-24 1985-10-29 Verwendung von Adenosin zur Herstellung eines Arzneimittels f}r kontinuierliche Intraven¦se Infusionan menschlichen Patienten
DE3588205T Expired - Lifetime DE3588205T2 (de) 1985-09-24 1985-10-29 Verwendung von Adenosin zur Herstellung eines Arzneimittels für kontinuierliche Intravenöse Infusion an menschlichen Patienten

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE19853590855 Withdrawn DE3590855T1 (de) 1985-09-24 1985-10-29

Family Applications After (2)

Application Number Title Priority Date Filing Date
DE1999175044 Active DE19975044I2 (de) 1985-09-24 1985-10-29 Verwendung von Adenosin zur Herstellung eines Arzneimittels f}r kontinuierliche Intraven¦se Infusionan menschlichen Patienten
DE3588205T Expired - Lifetime DE3588205T2 (de) 1985-09-24 1985-10-29 Verwendung von Adenosin zur Herstellung eines Arzneimittels für kontinuierliche Intravenöse Infusion an menschlichen Patienten

Country Status (9)

Country Link
EP (2) EP0275249B2 (de)
JP (1) JP2535504B2 (de)
AT (2) ATE84419T1 (de)
AU (1) AU613304B2 (de)
CA (1) CA1301652C (de)
DE (4) DE3590855T1 (de)
DK (1) DK253187D0 (de)
NZ (1) NZ217592A (de)
WO (1) WO1987001593A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3782427T2 (de) * 1986-10-06 1996-07-18 Univ Virginia Verwendung einer adenosin, hypoxanthin und ribose enthaltender lösung zur schonung des herzens während chirurgischer eingriffe.
US5070877A (en) * 1988-08-11 1991-12-10 Medco Research, Inc. Novel method of myocardial imaging
US6004945A (en) 1990-05-10 1999-12-21 Fukunaga; Atsuo F. Use of adenosine compounds to relieve pain
US5677290A (en) * 1990-05-10 1997-10-14 Fukunaga; Atsuo F. Therapeutic use of adenosine compounds as surgical anesthetics
US5256398A (en) * 1990-11-08 1993-10-26 Whitby Research, Inc. Composition for determining viability of tissue
US5681278A (en) * 1994-06-23 1997-10-28 Cormedics Corp. Coronary vasculature treatment method
CN103260670A (zh) 2010-10-15 2013-08-21 塞托弗尔克斯股份有限公司 细胞分离灌流器及其用途
EP2766065A4 (de) 2011-10-14 2016-06-15 Cytopherx Inc Patrone und verfahren zur erhöhung der herzmuskelfunktion
EP2783651A4 (de) * 2011-11-21 2014-10-01 Denerve Inc Nierenarterien-ablationskatheter und -system

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845205A (en) * 1970-06-04 1974-10-29 Univ Sydney 2-loweralkylthioadenosines
FR2129833B1 (de) * 1971-03-16 1974-08-02 Cerm Cent Europ Rech Mauvernay
ZA7464B (en) * 1973-01-16 1974-11-27 J Voorhees Treatment of proliferating skin diseases with papavine alkaloids
DE3133925A1 (de) * 1981-08-27 1983-03-17 A. Nattermann & Cie GmbH, 5000 Köln Arzneimittel zur behandlung von hypertonie
DE3406533A1 (de) * 1984-02-23 1985-08-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verwendung von adenosin-derivaten als antiallergica und arzneimittel, die diese enthalten

Also Published As

Publication number Publication date
CA1301652C (en) 1992-05-26
ATE84419T1 (de) 1993-01-15
WO1987001593A1 (en) 1987-03-26
AU5065585A (en) 1987-04-07
DE3586993T2 (de) 1993-04-29
DE3588205D1 (de) 1999-03-11
EP0275249B2 (de) 1997-12-17
JP2535504B2 (ja) 1996-09-18
DE3586993T3 (de) 1998-03-19
EP0275249B1 (de) 1993-01-13
EP0506205A1 (de) 1992-09-30
DE19975044I2 (de) 2006-02-02
AU613304B2 (en) 1991-08-01
NZ217592A (en) 1990-10-26
DE3588205T2 (de) 1999-06-02
DK253187A (da) 1987-05-19
JPS63501497A (ja) 1988-06-09
EP0506205B1 (de) 1999-01-27
DK253187D0 (da) 1987-05-19
EP0275249A1 (de) 1988-07-27
DE3590855T1 (de) 1988-08-25
ATE176154T1 (de) 1999-02-15

Similar Documents

Publication Publication Date Title
DE60238142D1 (de) Implantierbares system
DE59108854D1 (de) Arzneimittel sowie deren herstellung und deren verwendung bei der bekämpfung von schmerzen und/oder entzündungen an tieren und menschen
DE69431281D1 (de) Herzschrittmacher mit elektrode und integriertem sauerstoff-fühler
DE3586993D1 (de) Kontinuierliche intravenoese infusion von adenosin an menschlichen patienten, einheitsdosierungsform von adenosin und dessen verwendung bei der herstellung von arzneimitteln.
SE8506029L (sv) Hjert-lungsystem avsett for syresettning av en patients blod
KR890001580A (ko) B형 간염 바이러스에 의해 유발되는 염증 질환을 치료하는 이중가닥 rna를 함유하는 약물
Rausch et al. Platelet serotonin uptake in depressed patients: circadian effect.
DE3781054T2 (de) Die verwendung von d-fenfluramin zur herstellung von arzneimitteln, zur behandlung von depressionen.
Orenstein et al. Behavioral aspects of cystic fibrosis.
Thomas et al. Circulatory, psychological & performance variables during 100 hours of paced continuous exercise under conditions of controlled energy intake & work output.
Kopera Lack of anticholinergic and cardiovascular effects of mianserin: Studies in healthy subjects and heart patients.
Davis et al. Comparison of changes in blood volume and opacity in dog digital pad and tongue.
Szatmary et al. Haemodynamic and antiischaemic protective effects of intra-aortic balloon counterpulsation in high risk coronary heart patients undergoing percutaneous transluminal coronary angioplasty
DE3750248T2 (de) Zubereitung und Behandlung der Haut mit Human-Leukocyten-Interferon.
DE3876425T2 (de) Gesteuerte verabreichung eines heilmittels an blut.
ATE84418T1 (de) 2,6-diamino-3-phenyl-azo-pyridin enthaltendes tier- und humanarzneimittel mit antiviraler und antitumoraler aktivitaet.
Mason The psychotropic drug summary.
Visher Counseling stepfamilies.
IT8412421A1 (it) Elettrostimolatore cardiaco impiantabile, di tipo fisiologico, in cui le frequenza di stimolazione controllata dalla media della velocità di deformazione del torace causata dalla respirazione del paziente
Tiu et al. Anti-Arrhythmic and Inotropic Action of Lb-46 With Paired Pacing
Chung Case 79 AF with advanced AV block causing frequent ventricular escape beats suggestive of SSS
IT8315255V0 (it) Elettrostimolatore cardiaco impiantabile di tipo fisiologico in cui la frequenza di stimolazione e regolata dalla frequenza respiratoria del paziente
Bellomo Art therapy and its use in a psychiatric hospital setting.
Somelofski et al. Antiarrhythmic therapy: The issue of patient compliance.
IT8204818V0 (it) Elettrostimolatore cardiaco impiantabile,di tipo fisiologico, in cui la frequenza di stimolazione e' regolata dalla frequenza respiratoria del paziente

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings
8339 Ceased/non-payment of the annual fee